Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
3 of 6 columns
Comparison
| Attribute | Veraxa Biotech Holding AG14.4remove | Acurx Pharmaceuticals, Inc.14.3remove | Tempest Therapeutics, Inc.15.2remove |
|---|---|---|---|
| Signal scores | |||
| Radar composite | 14.4 | 14.3 | 15.2 |
| IPO signal score | 28.7 | 28.7 | 30.3 |
| Tokenization signal score | 0.0 | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 | 0.0 |
| Momentum | STABLE+4.8 | ACCELERATING+18.5 | ACCELERATING+15.0 |
| Company | |||
| Stage | filed | filed | filed |
| Sector | not on record | not on record | not on record |
| Headquarters | ZURICH | STATEN ISLAND | BRISBANE |
| Founded | not on record | not on record | not on record |
| Employees | not on record | not on record | not on record |
| Capital | |||
| Latest valuation | not on record | not on record | not on record |
| Total funding | not on record | not on record | not on record |
| Latest round | not on record | not on record | not on record |
| Investors on record | 0 | 0 | 0 |
| Evidence | |||
| Institutional relationships | 0 | 0 | 0 |
| Active signals | 16 | 20 | 46 |
| Confidence | 79% | 80% | 80% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.